@article{e1a79392cc35486e9d3f9310ce7c450f,
title = "SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer.",
keywords = "PHASE-III TRIAL, ELDERLY-PATIENTS, ANTITUMOR-ACTIVITY, 2ND-LINE THERAPY, INTERFERON-ALPHA, POOLED ANALYSIS, CARCINOMA, TEMSIROLIMUS, PROGRESSION, STRATEGIES",
author = "Christian Eichelberg and Vervenne, {Walter L} and {De Santis}, Maria and {Fischer von Weikersthal}, Ludwig and Goebell, {Peter J} and Christian Lerchenm{\"u}ller and Uwe Zimmermann and Bos, {Monique M E M} and Werner Freier and Silke Schirrmacher-Memmel and Michael Staehler and Sascha Pahernik and Maartje Los and Marcus Schenck and Anne Fl{\"o}rcken and {van Arkel}, Cornelis and Kirsten Hauswald and Martin Indorf and Dana Gottstein and Michel, {Maurice S}",
year = "2015",
doi = "10.1016/j.eururo.2015.04.017",
language = "English",
volume = "68",
pages = "83--47",
journal = "EUROPEAN UROLOGY ",
issn = "0302-2838",
publisher = "Elsevier ",
number = "5",
}